GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Modern Endoscopic Management of Flat Colonic Neoplasia : Endoscopy | June 2026

Modern Endoscopic Management of Flat Colonic Neoplasia : Endoscopy | June 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated June 1, 2026

Quick Answer

Introduction: Non-pedunculated colonic neoplasia (NPCN), including flat and sessile colorectal lesions, is being detected with increasing frequency due to widespread colorectal cancer screening and advances in high-definition endoscopy. Compared with pedunculated polyps, these lesions present greater challenges because of their higher risk of submucosal invasion, incomplete resection, and recurrence.


Introduction:

Non-pedunculated colonic neoplasia (NPCN), including flat and sessile colorectal lesions, is being detected with increasing frequency due to widespread colorectal cancer screening and advances in high-definition endoscopy. Compared with pedunculated polyps, these lesions present greater challenges because of their higher risk of submucosal invasion, incomplete resection, and recurrence. Consequently, accurate lesion characterization and appropriate selection of resection technique are essential for optimal patient outcomes.

Problem Statement:

The expanding range of endoscopic imaging technologies and resection techniques has created increasing complexity in the management of NPCN. Clinicians must determine which lesions can be safely treated with cold resection techniques, which require advanced endoscopic interventions, and which should be referred for surgery. Clear guidance is needed to integrate evolving evidence into routine clinical practice.

Summary:

This review provides a contemporary overview of the diagnosis and management of NPCN, highlighting major advances that have reshaped endoscopic practice over the past decade. Modern optical diagnosis systems, including NICE, JNET, and Kudo pit pattern classifications, now enable more accurate real-time assessment of lesion histology and invasion depth, facilitating informed therapeutic decision-making. Cold snare polypectomy and cold EMR have emerged as preferred approaches for small and intermediate-sized lesions because of their excellent safety profile and high rates of complete resection. For lesions measuring 20 mm or larger, piecemeal EMR combined with systematic margin ablation using snare-tip soft coagulation has become the standard approach, substantially reducing recurrence rates. The review also discusses the growing role of underwater EMR, cap-assisted EMR, and endoscopic full-thickness resection for challenging fibrotic or non-lifting lesions. ESD remains an important technique when en bloc resection is required, particularly in lesions with suspected superficial submucosal invasion, although its adoption varies according to local expertise and service infrastructure. Looking ahead, artificial intelligence-assisted optical diagnosis, standardized training pathways, and robust quality metrics are expected to further improve outcomes. Overall, the review reinforces a lesion-specific, evidence-based approach to NPCN, emphasizing accurate optical diagnosis and tailored resection strategies as the foundation of high-quality colorectal endoscopic care.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer